BridgeBio Oncology Therapeutics Cash Flow Statement (2024-2026) | BBOT

Cash Flow Statement Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter) 1.14M2.29M-17.11M-64.81M-21.15M0.95M-85.02M-86.18M-62.09M-70.81M
Depreciation and Depletion (Quarter) 0.04M0.05M0.08M0.10M0.10M
Share-based Compensation (Quarter) 0.66M0.28M0.77M2.29M0.63M0.88M1.43M61.50M7.23M
Cash from Operations (Quarter) -0.62M-0.03M-39.34M-15.04M-19.60M18.57M-70.63M-42.23M-35.92M-44.36M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.41M0.11M0.07M-0.41M
Depreciation & Amortization (CF) (Quarter) 0.04M0.05M0.08M0.10M0.10M
Change in Working Capital
Change in Account Payables (Quarter) 1.96M0.54M-0.50M0.54M-2.42M10.69M-5.33M
Change in Accured Expenses (Quarter) 0.01M0.06M1.98M-1.90M-1.92M4.32M-2.41M17.68M0.30M14.62M
Other Working Capital Changes (Quarter) -0.12M-0.12M-0.13M
Investing Activities
Capital Expenditures (Quarter) 0.01M0.03M0.21M0.02M1.56M
Change in Acquisitions & Divestments (Quarter) 25.57M39.96M28.88M26.26M53.31M
Cash from Investing Activities (Quarter) -184.00M37.91M25.56M15.37M7.77M-285.41M45.73M
Financing Activities
Other financing activities (Quarter) 0.04M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter) 0.21M
Change in Capital Stock
Shares Issued (Quarter) 3.64M8.23M9.04M2.23M12.60M
Net Equity Issued and Repurchased (Quarter) 193.35M0.02M-22.22M22.22M
Misc.
Cash from Financing Activities (Quarter) 0.04M
Change in Cash (Quarter) 1.41M
Free Cash Flow (Quarter) -45.92M
Net Cash Flow (Quarter) 1.41M